Repeated GON injections for chronic cluster headache relief
Official title: Repeated Corticosteroid Injections Around the Greater Occipital Nerve (GON) as Prophylactic Treatment in Chronic Cluster Headache
Run by Leiden University Medical Center · NCT05324748 · Data updated 2026-11-12
This study is testing if repeated injections in the back of the head can help people with chronic cluster headaches have fewer headache attacks.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Leiden University Medical Center Academic / other |
| Locations | 2 sites (Leiden and 1 other locations) |
| Status | Recruiting |
| Started | November 7, 2022 |
| Main results expected | December 2025 |
| Study ends | June 2026 |
| Registry record updated | November 24, 2025 |
| Trial ID | NCT05324748 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 70 with a diagnosis of chronic cluster headache experiencing at least four attacks per week.
✕Probably not a fit
Patients with contraindications to corticosteroids, those using anticoagulants, or individuals with other headache disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of repeated greater occipital nerve (GON) injections as a prophylactic treatment for chronic cluster headache. It is a bi-centre, randomized, double-blind, placebo-controlled trial involving patients diagnosed with chronic cluster headache according to the ICHD-3 criteria. Participants will receive either GON injections with corticosteroids or a placebo, with the primary goal of determining if the injections can reduce the frequency of headache attacks over a one-year follow-up period. The study aims to provide insights into the long-term benefits and safety of this treatment approach.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce the frequency of cluster headache attacks for patients suffering from this debilitating condition.
How similar studies have gone: While GON injections have shown promise in treating episodic cluster headaches, this specific approach of repeated injections in chronic cases has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 and ≤ 70 years * Chronic cluster headache (International Classification of Headache Disorders - third edition; ICHD-3) * Ictal pain must be always at the same side * ≥4 weekly attacks of cluster headache in the prospective one-month baseline observation period * On a stable regimen of cluster headache prophylactics for \>4 weeks prior to onset of study treatment and agreeing not to increase the dose and not starting a new cluster prophylactic during the study period Exclusion Criteria: * Contra-indication against, or current use of, corticosteroids * Occipital nerve stimulation (ONS) * Use of anticoagulation medication or a known bleeding disorder * Inability to use an electronic diary to monitor individual attacks and other items * Other headaches if the patient cannot reliably distinguish them from attacks of cluster headache * Current use of prophylactic medication for other headaches * Pregnancy
Where it's running
-
Leiden University Medical Center
Leiden, Netherlands Recruiting -
Canisius Wilhelmina Ziekenhuis
Nijmegen, Netherlands Recruiting
Study contacts
- Study coordinator: Willemijn Naber
- Email: w.c.naber@lumc.nl
- Phone: 0715262587
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A real-world look at trigeminal autonomic cephalalgias in Italy
This study follows adults with TACs like cluster headache and related conditions in routine care to see how treatments work and what factors influence outcomes over time.
-
Magnesium sulfate for acute non-traumatic headache in the ED: 2 g vs 4 g vs standard paracetamol
This study tests whether intravenous magnesium sulfate given in different doses helps adults with acute non-traumatic headache in the emergency department, compared with paracetamol.
-
Using light therapy to treat chronic cluster headaches
This study is testing whether light therapy using a special device can help people with chronic cluster headaches feel better.
-
Noninvasive vagus nerve stimulation for prevention and treatment of primary headaches in children and teens
We will try a noninvasive ear-based vagus nerve stimulator to treat sudden primary headache attacks in children and adolescents aged 7–20.
-
Transcranial Direct Current Stimulation for Long COVID with Headaches and Chronic Pain
This study tests whether applying mild brain stimulation (tDCS) can help people with long COVID who have headaches, migraines, and ongoing pain.
-
Registry for headache and vertigo conditions in China
This study is collecting information from people of all ages who have headaches or vertigo to see how different treatments work and how these conditions relate to other health issues.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.